Covadonga Lopez-Sors

Covadonga Lopez-Sors started their work experience in 2006 as a Junior Product Manager at GSK. Covadonga then worked at MilliporeSigma from 2007 to 2008 as part of the Marketing and Communication team. In 2008, they joined Simon-Kucher & Partners as a Consultant and later became a Senior Consultant in 2011. From 2014 to 2018, Covadonga served as the Director at Simon-Kucher & Partners. In 2018, they moved to Insud Pharma as the Business Strategy, Portfolio, and Pipeline Director until 2020. After that, from 2020 to 2021, they worked at FAES FARMA as the Global Franchise Head. Currently, Covadonga is working at Allergy Therapeutics as the International Market Access Manager since 2022.

Covadonga Lopez-Sors completed their education in a chronological order. Covadonga started their academic journey in the year 2000 by enrolling at the University of Navarra, where they pursued a degree in Biology. This program lasted from 2000 to 2005.

Following their undergraduate studies, Covadonga decided to further enhance their business acumen and enrolled at the ESIC Business & Marketing School in 2006. During their time there, they completed a Master's degree in Marketing Management, which they successfully obtained in 2007.

Continuing their dedication to professional development, Covadonga pursued an Executive MBA from the IESE Business School from 2011 to 2013. While the field of study for this degree is not specified, it can be inferred that their studies were focused on business administration and management.

Overall, Covadonga Lopez-Sors's education history includes a Bachelor's degree in Biology from the University of Navarra, a Master's degree in Marketing Management from the ESIC Business & Marketing School, and an Executive MBA from the IESE Business School.